Literature DB >> 31197420

[Postcardiac arrest treatment guide].

C Storm1, W Behringer2, S Wolfrum3, G Michels4, K Fink5, C Kill6, J Arrich7, C Leithner8, C Ploner8, H-J Busch9.   

Abstract

BACKGROUND: Treatment after cardiac arrest has become more complex and interdisciplinary over the last few years. Thus, the clinically active intensive and emergency care physician not only has to carry out the immediate care and acute diagnostics, but also has to prognosticate the neurological outcome. AIM: The different, most important steps are presented by leading experts in the area, taking into account the interdisciplinarity and the currently valid guidelines.
MATERIALS AND METHODS: Attention was paid to a concise, practice-oriented presentation. RESULTS AND DISCUSSION: The practical guide contains all important steps from the acute care to the neurological prognosis generation that are relevant for the clinically active intensive care physician.

Entities:  

Keywords:  Acute diagnosis; Interdisciplinary therapy; Neurological prognosis; Postresuscitation treatment; Targeted temperature management

Mesh:

Year:  2019        PMID: 31197420     DOI: 10.1007/s00063-019-0591-6

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  2 in total

Review 1.  [Guidelines of the European Resuscitation Council (ERC) on cardiopulmonary resuscitation 2021: update and comments].

Authors:  Guido Michels; Johann Bauersachs; Bernd W Böttiger; Hans-Jörg Busch; Burkhard Dirks; Norbert Frey; Carsten Lott; Nadine Rott; Wolfgang Schöls; P Christian Schulze; Holger Thiele
Journal:  Anaesthesist       Date:  2022-02       Impact factor: 1.041

Review 2.  [Core curriculum Medical intensive care medicine of the German Society of Medical Intensive Care and Emergency Medicine (DGIIN)].

Authors:  S John; R Riessen; C Karagiannidis; U Janssens; H-J Busch; M Kochanek; G Michels; C Hermes; M Buerke; S Kluge; M Baumgärtel; S Braune; F Erbguth; V Fuhrmann; P Lebiedz; K Mayer; U Müller-Werdan; M Oppert; F Sayk; D Sedding; C Willam; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-01-11       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.